Recruiting
Phase 2

sEphB4-HSA

Sponsor:

Vasgene Therapeutics, Inc

Code:

NCT03993106

Conditions

Kaposi Sarcoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

sEphB4-HSA

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-12-15. This information was provided to ClinicalTrials.gov by Vasgene Therapeutics, Inc on 2024-05-02.